New radiation approach targets lung cancer in patients with dangerous scarring
NCT ID NCT03485378
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study tests a precise type of radiation (SABR) for people with early-stage non-small cell lung cancer who also have interstitial lung disease, a condition that causes lung scarring. The goal is to see if this treatment can control the cancer while keeping side effects manageable. About 39 participants will be grouped based on the severity of their lung disease and followed for survival and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alberta Health Services, Cross Cancer Institude
Edmonton, Alberta, T6G 1Z2, Canada
-
CHUM Université de Montréal
Montreal, Quebec, H2X 0A9, Canada
-
Edinburgh Cancer Centre, Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
-
London Regional Cancer Program of the Lawson Health Research Institute
London, Ontario, N6A 4L6, Canada
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
UHN Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.